NervGen Pharma Corp.

NasdaqCM:NGEN Stock Report

Market Cap: US$199.7m

NervGen Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:NGEN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 May 26BuyUS$18,268Gianni RuffoloIndividual8,791US$2.08
26 May 26BuyUS$2,000,000Adam RogersIndividual800,000US$2.50
29 Apr 26BuyUS$15,912Harold PunnettIndividual4,250US$3.74
08 Apr 26SellUS$63,064Krista McKerracherIndividual15,000US$4.23
09 Mar 26SellUS$39,848Krista McKerracherIndividual10,000US$3.98
02 Mar 26SellUS$79,670Krista McKerracherIndividual20,000US$4.13
20 Feb 26SellUS$114,986Krista McKerracherIndividual30,000US$4.30
12 Feb 26SellUS$39,958Krista McKerracherIndividual10,000US$4.00
19 Nov 25BuyUS$2,000,000The Paul And Phyllis Fireman Charitable FoundationCompany952,381US$2.10
19 Nov 25BuyUS$1,800,000Adam RogersIndividual857,143US$2.10
19 Nov 25BuyUS$525,000Brian BayleyIndividual250,000US$2.10

Insider Trading Volume

Insider Buying: NGEN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NGEN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,131,2352.01%
Institutions4,542,8534.28%
VC/PE Firms10,000,0009.42%
General Public89,529,04884.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 45.8%.

Top Shareholders

Top 25 shareholders own 15.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.42%
PFP Biosciences Holdings
10,000,000US$18.8m0%no data
2.71%
The Paul And Phyllis Fireman Charitable Foundation
2,879,149US$5.4m0%no data
1.11%
Harold Punnett
1,179,782US$2.2m0.36%no data
0.53%
Brian Bayley
565,000US$1.1m0%no data
0.19%
PFG Investments, LLC
201,000US$377.9k0%0.02%
0.19%
Marshall Wace LLP
200,359US$376.7k0%no data
0.16%
RBC Dominion Securities Inc.
171,961US$323.3k0%no data
0.15%
Randall Kaye
160,000US$300.8k45.5%no data
0.14%
Merrill Lynch, Pierce, Fenner & Smith Incorporated
147,200US$276.7k0%no data
0.11%
Adam Rogers
119,497US$224.7k497%no data
0.082%
Integrated Wealth Concepts LLC
86,815US$163.2k0%no data
0.075%
Gianni Ruffolo
79,198US$148.9k12.5%no data
0.073%
Valley Forge Investment Consultants, Inc.
77,698US$146.1k0%0.04%
0.059%
BMO Asset Management Corp.
62,900US$118.3k0%no data
0.059%
CapFinancial Partners, LLC
62,367US$117.2k0%no data
0.058%
UBS Asset Management AG
61,517US$115.6k0%no data
0.05%
Bank of America Corporation
53,456US$100.5k0%no data
0.038%
Osaic Wealth, Inc.
39,991US$75.2k0%no data
0.035%
The Patriot Financial Group Insurance Agency, LLC
37,000US$69.6k0%no data
0.031%
Commonwealth Equity Services, LLC
33,350US$62.7k0%no data
0.03%
Cetera Investment Advisers LLC
31,400US$59.0k0%no data
0.029%
McKinley Carter Wealth Services, Inc.
30,892US$58.1k0%no data
0.026%
Krista McKerracher
27,758US$52.2k-35.1%no data
0.024%
Traynor Capital Management, Inc.
25,500US$47.9k0%no data
0.024%
Busey Trust Company
25,000US$47.0k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/13 12:55
End of Day Share Price 2026/07/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NervGen Pharma Corp. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raghuram SelvarajuH.C. Wainwright & Co.
Elemer PirosLucid Capital Markets
Michael OkunewitchMaxim Group